Condition: Multiple Sclerosis · Gait Disorders, Neurologic · Postural Balance · Sponsor: University of Patras
The goal of this observational cross-sectional study is to investigate the relationship between functional measures of balance and gait and objective kinetic and kinematic parameters in people with Multiple Sclerosis (MS). The main questions it aims to answer are: i) What is the relationship between kinetic and kinematic gait and balance parameters measured using the Vicon motion analysis system and performance on clinical functional assessments in people with Multiple Sclerosis? ii) Which biomechanical parameters are most strongly associated with functional balance, gait, and physical performance outcomes? Participants will attend a single laboratory-based assessment session. During this session, they will undergo biomechanical gait and balance analysis using the Vicon motion capture system, complete functional assessments of balance, gait, and physical performance, complete questionnaires assessing fear of falling and fatigue, and undergo assessment of lower-limb spasticity.
This description comes directly from the study's public registry record.
Eirini Papakosta, PT, MSc cand. · +30 6972355224 · up1075912@ac.upatras.gr
Sofia Lampropoulou, PT, MSc, PhD · +30 2610 962410 · lampropoulou@upatras.gr
Always discuss trial participation with your own doctor first.
| Division of Physical Medicine and Rehabilitation/Department of Surgery, University of Ioannina Medical School | Ioannina, Greece | Recruiting |
| Department of Physiotherapy of the School of Health Rehabilitation Sciences, University of Patras | Pátrai, Greece | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07630311